A, U., Y, R., B, H., A, F., S, C., F, J., . . . P, G. (2024). Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 79(1), 198. https://doi.org/10.1093/cid/ciae006
Chicago Style (17th ed.) CitationA, Ursenbach, et al. "Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 79, no. 1 (2024): 198. https://doi.org/10.1093/cid/ciae006.
MLA (9th ed.) CitationA, Ursenbach, et al. "Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 79, no. 1, 2024, p. 198, https://doi.org/10.1093/cid/ciae006.